Research memoGlobe Life Inc. (GL) · NYSEMemo of October 22, 2026By Olivier Lachance

Globe Life stock forecast 2027–2029

MyStockButler's October 2026 analysis: The weighted scenario for Globe Life reaches $173.29 in October 2027 from the October 22 price. Globe Life’s path hinges on durable earnings, policy retention, and capital reaching the parent.

165.87
Share price today, USD
191.09 (+18 %)
Weighted scenario, October 2029
11.1x
P/E, last 12 months
1.9x
Price to book
Read the full Globe Life memoYour first S&P 500 report is free · no card
Every number traced to Globe Life's filings8 chapters · 19,371 words223 sources cited

Where could Globe Life’s shares be by 2029?

The forecast points to modest upside, with substantial downside and upside risk. The weighted price reaches $173.29 in October 2027, $181.97 in October 2028, and $191.09 in October 2029. Including dividends, those outcomes represent returns of 5%, 11%, and 18% from today’s $165.87.

The range is much wider by the final date: $117.71 in the bear case to $270.43 in the bull case. The base case receives the highest probability because book value has risen, share count has fallen, and management still targets moderate earnings growth.

Globe Life share price scenarios for October 2029: bear $117.71, base $209.48, bull $270.43
What the shares could be worthUSD per share at each date; in brackets the return since today's 165.87, dividends included
CaseProbabilityOctober 2027October 2028October 2029
Bear30 %134.92 (-18 %)122.19 (-25 %)117.71 (-27 %)
Base55 %184.94 (+12 %)198.04 (+21 %)209.48 (+29 %)
Bull15 %207.27 (+26 %)242.61 (+48 %)270.43 (+66 %)
Weighted100 %173.29 (+5 %)181.97 (+11 %)191.09 (+18 %)

What this means. The Weighted row is the average value after giving each case its stated probability, not a promise that the shares will be worth exactly that amount.

What has to go right or wrong for Globe Life?

The bear case requires health claims to remain elevated, renewal retention to weaken, reserve gains to fade, and borrowing to support buybacks. It gives $134.92 in October 2027 and $117.71 in October 2029, with a 30% probability. The probability reflects visible pressure in health claims and the reduced earnings outlook, although rising book value and stable capital ratios argue against a deeper collapse.

The bull case requires claims to normalize, repricing to preserve retention, and agent and worksite initiatives to produce persistent policies. It gives $207.27 in October 2027 and $270.43 in October 2029, with a 15% probability. That outcome needs several favorable developments together, while recent guidance reductions and uneven delivery make it less likely than stabilization.

How much cash does Globe Life really make?

Operating cash flow was 1,396,391 in 2025, above net income of 1,161,238. But the reconciliation included 582,136 from increased future policy benefits. Customers paid cash before many claims became due, so the cash arrived alongside a larger obligation.

What does an investor pay for Globe Life today?

What an investor pays todayUS$ thousands
Today (Oct 22, 2026)
Share price165.87
Market value (calculated)12,616,543.768
P/E, last 12 months (calculated)11.1x
P/E on core earnings, last 12 months (calculated)10.9x
P/E, next 12 months (calculated)10.5x
Price to book (calculated)1.9x
Dividend yield (calculated)0.8%

What this means. The next year's price-to-earnings ratio uses analysts' guesses about future profit, so it can change and is not a fact yet.

From the full memo · 1. The business

Globe Life is an insurer that sells life insurance and supplemental health insurance, chiefly to households seeking manageable payments and protection from financial shocks. Its business is a continuing exchange: customers pay premiums, Globe Life invests and manages that money, and the company pays valid claims and other costs.

Continue reading, free
Your first S&P 500 report is free · no card

Where these numbers come from

More on Globe Life

Globe Life dividendAuf Deutsch

Its rivals

Aflac (AFL)MetLife (MET)Chubb (CB)UnitedHealth (UNH)

Browse

All stocksS&P 500 companiesCompanies GBloomberg Terminal alternatives
The full Globe Life memoYour first S&P 500 report is free
Read it